November 08, 2022, Prakash Nagarkatti and Mitzi Nagarkatti
Immunologists Prakash Nagarkatti and Mitzi Nagarkatti write for The Conversation on how the immune system reacts during infections, vaccinations and autoimmune diseases where the body starts attacking itself.
April 19, 2022, Prakash Nagarkatti and Mitzi Nagarkatti
As mRNA vaccines used in the U.S. against COVID-19 have been successful at preventing hospitalization and death, the vaccines have failed to provide long-term protective immunity to prevent breakthrough infections. School of Medicine Columbia professors Prakash Nagarkatti and Mitzi Nagarkatti write for The Conversation on the COVID-19 booster and retooling existing vaccines to increase the duration of protection.
March 22, 2022, Prakash Nagarkatti and Mitzi Nagarkatti
The COVID-19 omicron variant has been the predominant source of rising infections around the world. BA.2 is the latest subvariant of omicron and is spreading quickly in many countries. School of Medicine Columbia professors, Prakash Nagarkatti and Mitzi Nagarkatti, write for The Conversation on this new strain, if there will be another surge in the U.S. and how to protect yourself.
February 25, 2022, Prakash Nagarkatti and Mitzi Nagarkatti
Prakash Nagarkatti and Mitzi Nagarkatti, professors of pathology, microbiology and immunology, write for The Conversation on Covid-19 protective immunity via vaccination and infection.
April 30, 2020, Prakash Nagarkatti and Mitzi Nagarkatti
In the context of the coronavirus pandemic, who is the “fittest”? This is a challenging question. But as immunology researchers at the University of South Carolina, we can say one thing is clear: With no effective treatment options, survival against the coronavirus infection depends completely on the patient’s immune response. School of Medicine Columbia professors Prakash Nagarkatti and Mitzi Nagarkatti write for The Conversation about immune response to COVID-19.